DALLAS, TX — November 6, 2018 — InvestorsHub NewsWire — Puration, Inc. (USOTC: PURA) (“PURA”) today announced the first order of its brand new Telluride Happy Water. The twelve-pallet order will be heading to Colorado for distribution in marijuana dispensaries. “We’re thrilled with the order and Colorado is the right place to introduce Telluride Happy Water,” said Brian Shibley, CEO of Puation.
Telluride Happy Water is refreshing and delicious drink that enhances the cannabis experience as a beverage before partaking or during when used in a water-pipe. Telluride Happy Water has a higher level of dissolved oxygen in it than almost any bottled water on the market. A patented technology and formula reduces the size of water molecules which creates a platform that accelerates the uptake of anything mixed with or filtered through the patented water technology. This is how Telluride Happy Water exponentially increases a cannabis high.
The cannabis-infused edibles market is projected to make up a $2.3-billion market in 2018 and to become a $5.3-billion market within the next five years, according to data from cannabis market research firm Brightfield Group.
Puration yesterday released an online presentation with details on the recent acquisition of the Telluride Health Company and the plans for integrating the operation into PURA’s overall cannabis beverage business model.
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.